Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Michelle Lerner

Physician Assistant, Medical Danbury, CT Physician Assistant

NPI 1326172321 CMS profile 10653364

24 Hospital Ave, Danbury, CT 06810

Open in the dashboard

General payments

$4,033

201 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Michelle Lerner of Danbury, CT is reported in the CMS Open Payments database as having received $4,033 across 201 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $21 1
2023 General $1,311 59
2022 General $1,322 66
2021 General $1,378 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michelle Lerner
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Michelle Lerner were reported at $0. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Michelle Lerner Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,378 $156 $41–$563 $132
2022 $1,322 $185 $55–$649 $149
2023 $1,311 $199 $58–$717 $160
2024 $21 $206 $62–$740 $164
2025 $0 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Teva Pharmaceuticals USA, Inc. $630 34 payments
  2. AbbVie, Inc. $489 24 payments
  3. Lilly USA, LLC $430 21 payments
  4. Neurocrine Biosciences, Inc. $315 12 payments
  5. Biohaven Pharmaceuticals, Inc. $221 12 payments
  6. Almatica Pharma LLC $217 14 payments
  7. Biohaven Pharmaceutical Holding Company Ltd. $172 10 payments
  8. Pfizer Inc. $155 7 payments
  9. Eisai Inc. $142 7 payments
  10. ITI, Inc. $137 6 payments
  11. Other $1,127 54 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $4,032 198 payments
  2. Education $1 3 payments
Products named General payments · program years 2021–2024
  1. AUSTEDO $401 20 payments
  2. NURTEC ODT Primary Care $393 22 payments
  3. EMGALITY $312 16 payments
  4. REYVOW $267 14 payments
  5. UBRELVY $242 12 payments
  6. GRALISE $217 14 payments
  7. INGREZZA $183 6 payments
  8. Ongentys $183 6 payments
  9. NAPRELAN $178 12 payments
  10. NURTEC ODT Pain $155 7 payments
  11. Other $2,824 123 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

201 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record